siRNA, Anti-TAB2, 2'-F/2'-OMe/2'-MOE/Ribo/Backbone-modified(CAT#: SIRGT36700WQ-2OMe)

The product SIRGT36700WQ-2OMe is a type of small interfering RNA (siRNA) that targets TAB2 gene and regulates the expression of gene. The siRNA interferes with the expression of TAB2 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_001292034.2
Alternative Names CHTD2; MAP3K7IP2; TAB-2
Related Diseases Polyvalvular Heart Disease Syndrome
Purification HPLC
Target Gene
Gene ID 23118
Uniprot ID Q9NYJ8
Sub Cat Target Species Modification Scale  
SIRGT37700WQ-2F TAB2 Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT38700WQ-2MOE TAB2 Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT36700WQ-RB TAB2 Human Ribo-modified Inquiry
SIRGT37700WQ-BB TAB2 Human Backbone-modified Inquiry

Related Products